I'm Aileen.
I've spent many years in clinical operations: CRO-side, sponsor-side, and a stint at an academic medical center that taught me how much harder this work gets when budgets are tight and tools are duct-taped together.
This blog exists because I kept answering the same questions: What does E6(R3) actually require? How do I set up a TMF that won't embarrass me at inspection? What's the minimum viable process for a Phase I with three sites and no dedicated QA?
Most GCP guidance out there is either regulatory boilerplate or enterprise-focused advice that assumes you have a compliance department down the hall. I write for the clinical ops leads, study coordinators, and project managers doing this work without that safety net.
Practical. No jargon tourism. If I can't explain how to actually implement something, I won't waste your time with it.
I do my homework, but regulations change, interpretations vary by region, and I'm one person, not a regulatory body. When I link to official sources, guidance documents, or regulations, check them yourself before making decisions that matter. Your context is yours; I'm just here to point you in the right direction.